Page 288 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 288
Fatty Liver Disease: Experimental (Cont.)
YI P0964 DIRECT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR
AGONISMAMELIORATES STEATOHEPATITISAND
FIBROSIS IN MODELS OF NASH AND BILIARY FIBROSIS
VIA REGULATION OF LIVER MACROPHAGE INFILTRATION
AND ACTIVATION
Xiao-Yu Wang*, Shih-Yen Weng, Thomas Klein,Yong Ook Kim,
Detlef Schuppan, Germany
YI P0965 HIGH FAT DIET TREATMENT OF CONDITIONAL C-MET
KO-MICE DEVELOP AN INFLAMMATORY PHENOTYPE
AND PROGRESS TO FIBROSIS INDEPENDENTLY FROM
STEATOSIS
Fabienne Schumacher*, Pierluigi Ramadori, Maximilian Hatting,
Nikolaus Gassler, Christian Trautwein, Konrad L. Streetz,
Daniela C. Kroy, Germany
YI P0966 ADIPOSE TISSUE INFLAMMATION OCCURS PRIOR TO
LIVER INFLAMMATION IN MICE FED A HIGH-FAT DIET
ePOSTERS Fareeba Sheedfar*, Roel A. Van Der Heijden, Martine C. Morrison,
Pascal H. Hommelberg, Sameh Youssef, Nanda Gruben, Alain De Bruin,
Marten H. Hofker, Robert Kleemann, Debby P. Koonen, Peter Heeringa,
The Netherlands
YI P0967 ROLE OF FATTY ACIDS FOR CHOLANGIOCYTE LIPID
METABOLISM AND LIPOTOXICITY
Irene Pierantonelli*, Thierry Claudel, Claudio Pinto,
Gianluca Svegliati Baroni, Michael Trauner, Austria, Italy
YI P0968 ARE THE TYPE OF PROBIOTIC STRAINS AND THEIR
AMOUNT EQUALLY EFFECTIVE FOR NAFLD PREVENTION:
EXPERIMENTAL COMPARATIVE STUDY?
Nazarii Kobyliak*, Oleksandr Virchenko, Tetyana Falalyeyeva,
Maryana Kondro, Galyna Mykhalchyshyn, Mykola Spivak,
Tetyana Beregova, Petro Bodnar, Ukraine
YI P0969 ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC
STEATOHEPATITIS DEVELOPMENT
Rocío Gallego-Durán*, Jose Antonio Del Campo, Javier Ampuero,
Marta García-Valdecasas, Lourdes Rojas, Helena Pastor-Ramírez,
Mª Jesús Pareja, Raquel Millán, Mª Carmen Rico, Antonio Gil-Gómez,
Ángela Rojas, Anabel Rojas, Manuel Romero-Gómez, Spain
288 The International Liver Congress™ 2015 • ILC Programme
YI P0964 DIRECT GLUCAGON-LIKE PEPTIDE-1 RECEPTOR
AGONISMAMELIORATES STEATOHEPATITISAND
FIBROSIS IN MODELS OF NASH AND BILIARY FIBROSIS
VIA REGULATION OF LIVER MACROPHAGE INFILTRATION
AND ACTIVATION
Xiao-Yu Wang*, Shih-Yen Weng, Thomas Klein,Yong Ook Kim,
Detlef Schuppan, Germany
YI P0965 HIGH FAT DIET TREATMENT OF CONDITIONAL C-MET
KO-MICE DEVELOP AN INFLAMMATORY PHENOTYPE
AND PROGRESS TO FIBROSIS INDEPENDENTLY FROM
STEATOSIS
Fabienne Schumacher*, Pierluigi Ramadori, Maximilian Hatting,
Nikolaus Gassler, Christian Trautwein, Konrad L. Streetz,
Daniela C. Kroy, Germany
YI P0966 ADIPOSE TISSUE INFLAMMATION OCCURS PRIOR TO
LIVER INFLAMMATION IN MICE FED A HIGH-FAT DIET
ePOSTERS Fareeba Sheedfar*, Roel A. Van Der Heijden, Martine C. Morrison,
Pascal H. Hommelberg, Sameh Youssef, Nanda Gruben, Alain De Bruin,
Marten H. Hofker, Robert Kleemann, Debby P. Koonen, Peter Heeringa,
The Netherlands
YI P0967 ROLE OF FATTY ACIDS FOR CHOLANGIOCYTE LIPID
METABOLISM AND LIPOTOXICITY
Irene Pierantonelli*, Thierry Claudel, Claudio Pinto,
Gianluca Svegliati Baroni, Michael Trauner, Austria, Italy
YI P0968 ARE THE TYPE OF PROBIOTIC STRAINS AND THEIR
AMOUNT EQUALLY EFFECTIVE FOR NAFLD PREVENTION:
EXPERIMENTAL COMPARATIVE STUDY?
Nazarii Kobyliak*, Oleksandr Virchenko, Tetyana Falalyeyeva,
Maryana Kondro, Galyna Mykhalchyshyn, Mykola Spivak,
Tetyana Beregova, Petro Bodnar, Ukraine
YI P0969 ROLE OF EPIGENETIC FACTORS IN NON-ALCOHOLIC
STEATOHEPATITIS DEVELOPMENT
Rocío Gallego-Durán*, Jose Antonio Del Campo, Javier Ampuero,
Marta García-Valdecasas, Lourdes Rojas, Helena Pastor-Ramírez,
Mª Jesús Pareja, Raquel Millán, Mª Carmen Rico, Antonio Gil-Gómez,
Ángela Rojas, Anabel Rojas, Manuel Romero-Gómez, Spain
288 The International Liver Congress™ 2015 • ILC Programme
